Background: Autologous hematopoietic stem cell transplantation (aHSCT) is a treatment option for a selected\ngroup of systemic sclerosis (SSc) patients with good available evidence but can be associated with considerable\nmorbidity and mortality. The aim of this study was to describe infectious complications and distinct immune\nreconstitution patterns after aHSCT and to detect risk factors in lymphocyte subsets, which are associated with an\nelevated rate of infections after aHSCT.\nMethods: Seventeen patients with SSc were included in this single-center retrospective cohort study. Clinical and\nlaboratory data was collected before and for 12 months after aHSCT, including immunophenotyping of peripheral\nwhole blood by fluorescence-activated cell sorting..........................
Loading....